Chun-guang Ma

发表

[Epidemiology of prostate cancer from three centers and analysis of the first-line hormonal therapy for the advanced disease].

X. Yao, B. Dai, Yi-jun Shen, 2008, Zhonghua wai ke za zhi [Chinese journal of surgery].

Tumor growth velocity: A modified tumor growth rate defining tumor progression during sorafenib treatment in patients with metastatic renal cell carcinoma

D. Ye, Hai-Liang Zhang, G. Shi, 2018, International journal of urology : official journal of the Japanese Urological Association.

Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer.

X. Yao, B. Dai, Yi-jun Shen, 2012, Urologic oncology.

Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma

D. Ye, Guohai Shi, Y. Qu, 2022, Cancer Immunology, Immunotherapy.

Identification and validation of novel metastasis-related signatures of clear cell renal cell carcinoma using gene expression databases.

D. Ye, Hai-Liang Zhang, G. Shi, 2020, American journal of translational research.

Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.

X. Yao, B. Dai, D. Ye, 2013, Asian journal of andrology.

Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells

X. Yao, B. Dai, Yi-jun Shen, 2010, Acta Pharmacologica Sinica.

Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes

B. Dai, Yi-jun Shen, D. Ye, 2019, World Journal of Surgical Oncology.

Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China

B. Dai, Yi-jun Shen, D. Ye, 2014, BJU international.

Extramammary Paget’s diseases in men from the Shanghai area: its association with PSA level increase*

X. Yao, B. Dai, Yi-jun Shen, 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma.

P. Lu, Jianji Pan, Y. Ba, 2021, European journal of cancer.

External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort.

Bo Dai, Chun-Guang Ma, Shi-Lin Zhang, 2012, Asian journal of andrology.

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma

D. Ye, Hai-Liang Zhang, G. Shi, 2021, Frontiers in Molecular Biosciences.

Prospectively packaged ilioinguinal lymphadenectomy for penile cancer: the disseminative pattern of lymph node metastasis.

X. Yao, B. Dai, Yi-jun Shen, 2009, The Journal of urology.

The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy?

X. Yao, B. Dai, Yi-jun Shen, 2012, Asian journal of andrology.

Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study

D. Ye, Hai-Liang Zhang, G. Shi, 2015, Oncotarget.

Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients.

X. Yao, B. Dai, Yi-jun Shen, 2009, Asian journal of andrology.

Clinical significance of TMPRSS 4 in prostate cancer

B. Dai, Yi-jun Shen, D. Ye, 2014 .

Clinical significance of TMPRSS4 in prostate cancer.

B. Dai, Yi-jun Shen, D. Ye, 2014, International journal of clinical and experimental pathology.

The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancer.

X. Yao, B. Dai, Yi-jun Shen, 2013, Asian journal of andrology.

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment

D. Ye, Guohai Shi, Y. Qu, 2021, Frontiers in Cell and Developmental Biology.

Association of glutathione S-transferase T1 and M1 polymorphisms with prostate cancer susceptibility in populations of Asian descent: a meta-analysis

B. Dai, Yi-jun Shen, D. Ye, 2015, Oncotarget.

A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma.

X. Yao, B. Dai, Yi-jun Shen, 2014, Future oncology.

Human epidermal growth factor receptor type 2 protein expression in Chinese metastatic prostate cancer patients correlates with cancer specific survival and increases after exposure to hormonal therapy.

X. Yao, B. Dai, D. Ye, 2008, Asian journal of andrology.

Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics

X. Yao, B. Dai, D. Ye, 2009, BJU international.

ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A

B. Dai, Yi-jun Shen, D. Ye, 2021, Cell Death & Disease.

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer

D. Ye, Hai-Liang Zhang, Y. Qu, 2021, Journal of cellular and molecular medicine.

Downregulation of EphA5 by promoter methylation in human prostate cancer

M. Guan, Xiao Xu, Xin-ju Zhang, 2015, BMC Cancer.

Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma

B. Dai, Yi-jun Shen, D. Ye, 2017, Journal of Cancer.

Evaluation of fine particles in surgical smoke from an urologist’s operating room by time and by distance

B. Dai, D. Ye, Hai-Liang Zhang, 2015, International Urology and Nephrology.

Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response

D. Ye, Hai-Liang Zhang, Y. Qu, 2021, Annals of medicine.

Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer

B. Dai, D. Ye, G. Lin, 2015, OncoTargets and therapy.

Individualized renal mass biopsy strategy for Chinese patients with different subtypes and necrosis area.

X. Yao, S. L. Zhang, B. Dai, 2013, Urologic oncology.

Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics

X. Yao, B. Dai, D. Ye, 2009, BJU international.

Polymorphisms at long non-coding RNAs and prostate cancer risk in an eastern Chinese population

Y. Zhu, B. Dai, G. Lin, 2014, Prostate Cancer and Prostatic Disease.